Cargando…

E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease

Chronic low-grade inflammation drives atherosclerosis and despite optimal pharmacological treatment of classical cardiovascular risk factors, one third of the patients with atherosclerotic cardiovascular disease has elevated inflammatory biomarkers. Additional anti-inflammatory strategies to target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poels, Kikkie, Vos, Winnie G., Lutgens, Esther, Seijkens, Tom T. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292335/ https://www.ncbi.nlm.nih.gov/pubmed/32582770 http://dx.doi.org/10.3389/fcvm.2020.00106

Ejemplares similares

Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem
por: Poels, Kikkie, et al.
Publicado: (2021)

Immuno-PET Imaging of Atherosclerotic Plaques with [(89)Zr]Zr-Anti-CD40 mAb—Proof of Concept
por: Poels, Kikkie, et al.
Publicado: (2022)

The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
por: Bosmans, Laura A., et al.
Publicado: (2020)

Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease
por: Lutgens, Esther, et al.
Publicado: (2020)

Antibody-Mediated Inhibition of CTLA4 Aggravates Atherosclerotic Plaque Inflammation and Progression in Hyperlipidemic Mice
por: Poels, Kikkie, et al.
Publicado: (2020)

Statins and immune checkpoint inhibitors: a strategy to improve the efficacy of immunotherapy for cancer?
por: Vos, Winnie G, et al.
Publicado: (2022)

The Spectrum of B Cell Functions in Atherosclerotic Cardiovascular Disease
por: Smeets, Diede, et al.
Publicado: (2022)

Increased atherosclerotic plaque in AOC3 knock-out in ApoE(−/−) mice and characterization of AOC3 in atherosclerotic human coronary arteries
por: Filip, Anna, et al.
Publicado: (2022)

Association Between Periodontal Disease and Atherosclerotic Cardiovascular Diseases: Revisited
por: Zardawi, Faraedon, et al.
Publicado: (2021)

Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue
por: Gabbiadini, Roberto, et al.
Publicado: (2023)

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
por: Wu, Min, et al.
Publicado: (2021)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
por: Bi, Lei, et al.
Publicado: (2022)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
por: Wang, Kexin, et al.
Publicado: (2022)

The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
por: Finney, Alexandra C., et al.
Publicado: (2023)

Common variable immunodeficiency—an independent risk factor for atherosclerotic cardiovascular diseases
por: Mattila, Juho, et al.
Publicado: (2023)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
por: Sudano, Isabella, et al.
Publicado: (2022)

Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2023)

Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability
por: Poels, Kikkie, et al.
Publicado: (2020)

NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease
por: Mullis, Caroline, et al.
Publicado: (2020)

Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor
por: Nahmias, Avital, et al.
Publicado: (2020)

Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation
por: Ma, Minglu, et al.
Publicado: (2023)

Effect of causative genetic variants on atherosclerotic cardiovascular disease in heterozygous familial hypercholesterolemia patients
por: Matta, Anthony, et al.
Publicado: (2023)

Immunotherapeutic Strategies in Cancer and Atherosclerosis—Two Sides of the Same Coin
por: Nettersheim, Felix Sebastian, et al.
Publicado: (2022)

The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis
por: Deng, Liangying, et al.
Publicado: (2022)

Proteotoxic stress response in atherosclerotic cardiovascular disease: Emerging role of heat shock factor 1
por: Ghai, Shruti, et al.
Publicado: (2023)

DNA methylation changes underlie the long-term association between periodontitis and atherosclerotic cardiovascular disease
por: Omar, Mohamed, et al.
Publicado: (2023)

Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
por: Aday, Aaron W., et al.
Publicado: (2019)

Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China
por: Liu, Hui, et al.
Publicado: (2023)

Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
por: Gourdy, Pierre, et al.
Publicado: (2023)

Perivascular adipose tissue in vascular pathologies—a novel therapeutic target for atherosclerotic disease?
por: Adachi, Yusuke, et al.
Publicado: (2023)

Endothelial nitric oxide synthase (eNOS) S1176 phosphorylation status governs atherosclerotic lesion formation
por: Nguyen, Tung D., et al.
Publicado: (2023)

The relationship between Type D personality with atherosclerotic plaque and cardiovascular events: The mediation effect of inflammation and kynurenine/tryptophan metabolism
por: Wang, Yini, et al.
Publicado: (2022)

Targeting E3 Ubiquitin Ligases and Deubiquitinases in Ciliopathy and Cancer
por: Shiromizu, Takashi, et al.
Publicado: (2020)

Antibody targeting of E3 ubiquitin ligases for receptor degradation
por: Marei, Hadir, et al.
Publicado: (2022)

Inflammatory Mediators in Atherosclerotic Vascular Remodeling
por: Evans, Bryce R., et al.
Publicado: (2022)

Effects of diagnostic ultrasound with cRGD-microbubbles on simultaneous detection and treatment of atherosclerotic plaque in ApoE(−/−) mice
por: Guo, Shengcun, et al.
Publicado: (2022)

Interaction analysis of the new pooled cohort equations for 10-year atherosclerotic cardiovascular disease risk estimation: a simulation analysis
por: Schiros, Chun G, et al.
Publicado: (2015)

Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study
por: Yang, Quanhe, et al.
Publicado: (2017)

Cumulative non-high-density lipoprotein cholesterol burden and risk of atherosclerotic cardiovascular disease: a prospective community-based study
por: Guan, Xu-Min, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_54smhfe6qs6bsd9eq1v4eijmig